![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Georgopapadakou N.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.6, Iss.2, 1997-02, pp. : 147-150
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
T-Cell-Targeted Biologicals for Psoriasis
Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 2, 2004-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. :